Long-Term Outcomes of Teplizumab in Routine Clinical Care

NCT07360080 · clinicaltrials.gov ↗

RECRUITING

Status

1000

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: Teplizumab

Sponsor

Sanofi